European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies.

Ignace Vergote, MD, PhD,* Eric Pujade-Lauraine, MD,* Sandro Pignata, MD,* Gunnar B. Kristensen, MD,* Jonathan Ledermann, MD,* Antonio Casado, MD,* Jalid Sehouli, MD,* Mansoor Mirza, MD,* Roldano Fossati, MD,* Christian Marth, MD,* Carine Creutzberg, MD,* Jose Del Campo, MD,* Nadeem Siddiqui, MD,* Paula Calvert, MD,* Aris Bamias, MD,* Gokhan Tulunay, MD,* Ate G.J. van der Zee, MD,* and Andreas du Bois, MD,* on behalf of the member trial groups of the European Network of Gynaecological Oncological Trial Groups (ENGOT)